Valdecoxib: the rise and fall of a COX-2 inhibitor

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.8, 2013-06, pp. : 1077-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Analogs of COX-2 Selective Inhibitors Lumiracoxib and Valdecoxib Derived from in silico Search and Optimization

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 1, 2014-03 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Reports of COX-2 inhibitor-associated arrhythmias in NZ

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The clinical developments and future of the COX-2 inhibitor drugs

By Goldstein Jerome

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 91-99

VSP

Access to resources Recommend Favorite

COX-2 inhibitor news from ACR/ARHP

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Lumiracoxib: new COX-2 inhibitor effective in osteoarthritis

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite